Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies
暂无分享,去创建一个
Leland S. Hu | Scott A. Whitmire | K. Swanson | M. Mrugala | K. Singleton | S. Johnston | Cassandra R. Rickertsen | G. de León | A. Porter | K. Clark-Swanson | K. Bond